To conclude, the present study illustrates the oncogenic role of NEAT1 like that of an lncRNA to facilitate the tumorigenesis and RB progression by binding to miR‐124 competitively and suggest the potential of NEAT1 as a target for RB therapy. This evidence concerns the gene NEAT1 and retinoblastoma.